The Novel Atypical Dopamine Uptake Inhibitor (S)-CE-123 Partially Reverses the Effort-Related Effects of the Dopamine Depleting Agent Tetrabenazine and Increases Progressive Ratio Responding-Reference-Cited by-同舟云学术

The Novel Atypical Dopamine Uptake Inhibitor (S)-CE-123 Partially Reverses the Effort-Related Effects of the Dopamine Depleting Agent Tetrabenazine and Increases Progressive Ratio Responding

Published:2019-06-28 Issue: Volume:10 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Rotolo Renee A.,Dragacevic Vladimir,Kalaba Predrag,Urban Ernst,Zehl Martin,Roller Alexander,Wackerlig Judith,Langer Thierry,Pistis Marco,De Luca Maria Antonietta,Caria Francesca,Schwartz Rebecca,Presby Rose E.,Yang Jen-Hau,Samels Shanna,Correa Merce,Lubec Gert,Salamone John D.

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference76 articles.

1. Paradigms for assessing hedonic processing and motivation in humans: relevance to understanding negative symptoms in psychopathology;Barch;Schizophr. Bull.,2017

2. Modafinil activates phasic dopamine signaling in dorsal and ventral striata;Bobak;J. Pharmacol. Exp. Ther.,2016

3. Perturbations in effort-related decision-making driven by acute stress and corticotropin-releasing factor;Bryce;Neuropsychopharmacology,2016

4. Differential effects of novel dopamine reuptake inhibitors on interference with long-term social memory in mice;Camats-Perna;Front. Behav. Neurosci.,2019

5. Novel and high affinity 2-[(diphenylmethyl)sulfinyl]acetamide (modafinil) analogues as atypical dopamine transporter inhibitors;Cao;J. Med. Chem.,2016

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological characterization of sex differences in the effects of dopaminergic drugs on effort-based decision making in rats;Psychopharmacology;2024-06-06

2. Unlocking the Potential of High-Quality Dopamine Transporter Pharmacological Data: Advancing Robust Machine Learning-Based QSAR Modeling;2024-03-11

3. Process Development and Scale-Up of a Novel Atypical DAT Inhibitor (S)-CE-123;ACS Omega;2024-03-04

4. Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors;Neuropsychopharmacology;2024-03-01

5. The Neurobiology of Activational Aspects of Motivation: Exertion of Effort, Effort-Based Decision Making, and the Role of Dopamine;Annual Review of Psychology;2024-01-18